Statistics

Total Visits

Views
A randomised, double-blind, parallel-group, phase 1 study comparing the pharmacokinetics, safety and efficacy of ct-p13 and infliximab in patients with active ankylosing spondylitis: 54 week results from the planetas study95

Select a period of time:

Number of views in the range

Views
A randomised, double-blind, parallel-group, phase 1 study comparing the pharmacokinetics, safety and efficacy of ct-p13 and infliximab in patients with active ankylosing spondylitis: 54 week results from the planetas study21

Views

Views
September 20252
October 20252
November 20256
December 20255
January 20265
February 20260
March 20261
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States11
Brazil8
United Kingdom1
Venezuela1
 

Top cities views

Views
San Jose4
Ashburn3
Caracas1
Caxias do Sul1
Cotia1
Curitiba1
Piúma1
Rio de Janeiro1
Salvador1
São Leopoldo1